Characterization of novel indenoindoles. Part I. Structure-activity relationships in different model systems of lipid peroxidation

Biochemical Pharmacology

Volumn 51, Issue 10, 1996, Pages 1397-1402

  Westerlund, Christer ^a   Östlund Lindqvist, Ann Margret ^a   Sainsbury, Malcolm ^b   Shertzer, Howard G ^c   Sjöquist, Per Ove ^a  

^a ASTRAZENECA R AND D   (Sweden)

^b UNIVERSITY OF BATH   (United Kingdom)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

antioxidants; free radicals; hypoxia; LDL modification

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BUTYLCRESOL; H 290 30; H 290 51; INDENOINDOLE DERIVATIVE; IRON; LOW DENSITY LIPOPROTEIN; ORGANIC SOLVENT; PHOSPHATIDYLCHOLINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TROLOX C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HYPOXIA; KIDNEY; LIPID PEROXIDATION; MOUSE; NONHUMAN; NORMAL HUMAN; OXIDATION REDUCTION POTENTIAL; PATHOPHYSIOLOGY; PERITONEUM MACROPHAGE; PLASMA; PRIORITY JOURNAL; RAT; REOXYGENATION; STRUCTURE ACTIVITY RELATION;

EID: 0029878802     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00080-9     Document Type: Article

References (19)

1. Halliwell B, Gutteridge JM and Cross CE, Free radicals, antioxidants, and human disease: Where are we now? J Lab Clin Med 119: 598-620, 1992.
2. Minotti G and Aust SD, The role of iron in oxygen radical-mediated lipid peroxidation. Chem Biol Interactions 71: 1-19, 1989.
3. Halliwell B, How to characterize a biological antioxidant. Free Rad Res Comms 9: 1-32, 1990.
4. Campo GM, Squadrito F, Iocolano M, Altavilla D, Calapai G, Zingarelli B, Scuri R and Caputi AP, Reduction of myocardial infarct size in the rat by IRFI-048, a selective analogue of vitamin E. Free Radic Biol Med 16: 427-435, 1994.
5. Zughaib ME, Tang XL, Schleman M, Jeroudi MO and Bolli R, Beneficial effects of MDL 74405 a cardioselective water-soluble α-tocopherol analogue, on the recovery of function of stunned myocardium in intact dogs. Cardiovasc Res 28: 235-241, 1994.
6. Steinberg D, Parthasarathy S, Carew TE, Khoo JC and Witztum JL, Beyond cholesterol. Modification of low density lipoprotein that increases its atherogenicity. N Engl J Med 320: 915-924, 1989.
7. Steinbrecher UP, Zhang H and Lougheed M, Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med 9: 155-168, 1990.
8. Esterbauer H, Puhl H, Dieber-Rotheneder M, Waeg G and Rabl H, Effect of antioxidants on oxidative modification of LDL. Annals Med 23: 573-581, 1991.
9. Shertzer HG, Sainsbury M, Graupner PR and Berger ML, Mechanisms of chemical mediated cytotoxicity and chemo prevention in isolated rat hepatocytes. Chem-Biol Interact 74: 123-141, 1991.
10. European patent application EP 481708 and EP 409410.
11. Yagi K, A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 15: 212-216, 1976.
12. Svensson L, Börjesson I, Kull B and Sjöquist P-O, Automated procedure for measuring TBARS for in vitro comparison of the effect of antioxidants on tissues. Scand J Clin Lab Invest 53: 83-85, 1993.
13. Lowry O, Rosenbrough N, Farr A and Randall R, Protein measurement with the folin phenol reagent. Biol Chem 193: 265-275, 1951.
14. Witztum JL, Mahoney EM, Braks MJ, Fisher M, Elam R and Steinberg D, Nonenzymatic glycosylation of low-density lipoprotein alters its biological activity. Diabetes 31: 283-291, 1982.
15. Brown DW, Graupner PR, Sainsbury M and Shertzer HG, New antioxidants incorporating indole and indoline chromophores. Tetrahedron 47: 4383-4408, 1991.
16. Sjöquist P-O, Svensson L, Sörensen V, Nilsson U, Pettersson S, Schersten T and Jonsson O, The new antioxidant H 290/ 51 improves function in reperfused kidneys. Free Radic Biol Med 2: H10 (Abstract), 1994.
17. Carew TE, Schwenke DC and Steinberg D, Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci USA 84: 7725-7729, 1987.
18. Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A, Yoshida H and Kawai C, Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA 84: 5928-5931, 1987.
19. Björkhem I, Henriksson-Freyschuss A, Breuer O, Diczfalusy U, Berglund L and Henriksson P, The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler Thromb 11: 15-22, 1991.